Big Pharma Patent Extension Abuse Threatens Healthcare and Human Rights

American pharmaceutical companies are facing a wave of protest from investors. AbbVie, Eli Lilly, Gilead, Johnson & Johnson, Merck and Pfizer are targeted by a shareholder engagement campaign to improve access to medicines and reduce costs. A common practice of laboratories is particularly targeted, that of the extension of the duration of patents which allows […]

Proponents as of mid-Feburary 2024 had filed at least 527 shareholder resolutions on environmental, social and related sustainable governance issues for the 2024 proxy season. This is down by only a few from 536 last year at the same time. It still seems possible the total will reach the 630-year-end total of last year.

CONTACT:Susana McDermottDirector of CommunicationsInterfaith Center on Corporate Responsibility (ICCR)201-417-9060 (mobile)smcdermott@iccr.org NEW YORK, NY, THURSDAY, APRIL 18, 2024 – Investors members of the Interfaith Center on Corporate Responsibility (ICCR) today announced that Coca-Cola ($KO) and Pepsi ($PEP) — two of the world’s largest beverage companies — would face shareholder proposals questioning the companies’ continued use of […]

By Christina Dorett, Seventh Generation Interfaith Coalition for Responsible Investment Sucrose is a natural sugar, a vital source of energy for our bodies, and Sucralose is a Non-Sugar Sweetener (NSS) or sugar substitute. Would you know the difference? It is not a coincidence that the names are deceptively similar. Aspartame is another widely used NSS […]

Though a growing cohort of investors is prepared to fight for equal access to medicine, the absence of strict pricing regulation remains a significant hurdle.

We write as members of the Interfaith Center on Corporate Responsibility (ICCR), a coalition of faith and values-based investors, in response to the request for comments by HHS on the implications of access and benefit sharing (ABS) commitments/regimes and other proposed commitments being considered under a WHO Convention, Agreement or Other International Instrument on Pandemic […]

Discover how the surge in ESG proposals is reshaping corporate America, with a focus on human rights, climate action, and the impact of AI. Explore the Vanguard of Change and the evolving landscape of financial activism beyond the balance sheet.

Report sheds light on key topics for ICCR members, with climate still in focus and AI rising up the agenda.

We are pleased to announce the release of ICCR’s 2024 Proxy Resolutions and Voting Guide. Our Guide presents the ICCR member-sponsored resolutions filed for 2024 corporate proxies as of February 15. The proposals included here illustrate ICCR’s guiding principle that sustainable corporations must look beyond the next earnings report to account for the full impact […]

The need to balance people and profit has always been a challenge for the pharmaceutical industry, but companies are now under increasing pressure to recognize their responsibility in the fight for global health equity. At the same time, with the rise of environmental, social and governance (ESG) considerations in investment processes, companies that don’t focus […]

As responsible investors, we advocate for corporate and systemic reforms that will improve the health and well-being of communities, especially those communities bearing a disproportionate burden of disease. For decades, faith-based investors working through the Interfaith Center on Corporate Responsibility (ICCR) have engaged leading pharmaceutical and other healthcare companies on concerns related to access and […]

Save the Date: Thursday, February 15th at 11:30 am ET to Hear about ICCR Member Proposals for the 2024 Proxy Season Join us on Thursday, 2/15 from 11:30 am to 12:30 pm ET, when we will share a preview of ICCR members’ 2024 shareholder proposals and our 2024 Proxy Resolutions and Voting Guide. Our webinar will help contextualize the more than 300 resolutions […]